Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's Lab - Quaterly Results

Date: 28-10-2022
The sales surged to Rs. 48803.00 millions, up 27.64% for the September 2022 quarter as against Rs. 38234.00 millions during the corresponding quarter previous year.The company almost doubled its revenue to Rs. 11163.00 millions  from Rs. 4490.00 millions in the quarter ended September 2022.Operating Profit saw a handsome growth to 19208.00 millions from 8664.00 millions in the quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 48803.00 38234.00 27.64 85109.00 72569.00 17.28 144052.00 133491.00 7.91
Other Income 1180.00 1181.00 -0.08 5214.00 3043.00 71.34 4820.00 8011.00 -39.83
PBIDT 19208.00 8664.00 121.70 29037.00 16145.00 79.85 30761.00 39379.00 -21.88
Interest 17.00 111.00 -84.68 115.00 176.00 -34.66 380.00 467.00 -18.63
PBDT 19191.00 8553.00 124.38 28922.00 15969.00 81.11 30381.00 38912.00 -21.92
Depreciation 2262.00 2066.00 9.49 4477.00 4037.00 10.90 8143.00 8350.00 -2.48
PBT 16929.00 6487.00 160.97 24445.00 11932.00 104.87 22238.00 30562.00 -27.24
TAX 5766.00 1997.00 188.73 8287.00 3308.00 150.51 6006.00 8698.00 -30.95
Deferred Tax 2790.00 841.00 231.75 3953.00 1168.00 238.44 2080.00 3297.00 -36.91
PAT 11163.00 4490.00 148.62 16158.00 8624.00 87.36 16232.00 21864.00 -25.76
Equity 832.00 832.00 0.00 832.00 832.00 0.00 832.00 832.00 0.00
PBIDTM(%) 39.36 22.66 73.69 34.12 22.25 53.35 21.35 29.50 -27.61